Funding for this research was provided by:
Helsingin Yliopisto (TYH2013343)
Sigrid Juséliuksen Säätiö (-)
Academy of Finland (317061)
Received: 2 December 2019
Accepted: 31 March 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: The Ethics Committee of the Department of Surgery in Helsinki University Central Hospital approved the FINNAKI study protocol with written informed consent from patients or their next of kin and the use of deferred consent.
: Not applicable.
: A.L. is listed as of the inventors on a patent on the use of HBP as a diagnostic tool in sepsis filed by Hansa Medical AB. All other authors declare that they have no competing interests.